# Post-Trial Access to ATH434 for Patients With Multiple System Atrophy

> **NCT07531433** · — · AVAILABLE · sponsor: **Alterity Therapeutics**

## Conditions studied

- Multiple System Atrophy

## Interventions

- **DRUG:** ATH434

## Key facts

- **NCT ID:** NCT07531433
- **Lead sponsor:** Alterity Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07531433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07531433, "Post-Trial Access to ATH434 for Patients With Multiple System Atrophy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07531433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*